Classes
DEA Class; Rx
Common Brand Names; Alcortin, Vytone
- Corticosteroids, Topical
Description
Topical combination product containing steroid and antibacterial/antifungal agent
Used for the treatment of skin infections
Indications
Indicated for the treatment of contact dermatitis, atopic dermatitis, impetiginized eczema/ impetigo, nummular eczema, endogenous chronic infectious dermatitis, stasis dermatitis, pyoderma, nuchal eczema, chronic eczematoid otitis externa, acne urticata, localized or disseminated neurodermatitis, lichen simplex chronicus, anogenital pruritus (vulvus, scrotum, anus), folliculitis, bacterial dermatoses (declatoses), mycotic dermatoses (tinea capitis, tinea cruris, tinea corporis, tinea pedis), moniliasis, and intertrigo.
Contraindications
Hypersensitivity
Hepatic insufficienty
Adverse Effects
Hydrocortisone
Skin atrophy
Striae
Acneform lesions
Pigmentation changes
HPA suppression (with higher potency used >2 wk)
Intracranial hypertension
Allergic contact dermatitis
Pruritus
Pustulation
Perioral dermatitis
Urticaria
Hypertrichosis
Leukoderma
Pigmentation changes
Iodoquinol
Fever
Vertigo
Chills
Headache
Skin eruptions
Urticaria
Rash
Chills
Thyroid gland enlargement
Anal itching
Diarrhea
Nausea/vomiting
Peripheral neuropathy
Optic neuritis
Optic atrophy
Warnings
Chronic topical corticosteroid therapy may interfere with growth and development in children
Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity
External use only
Use on extensive surface area or with occlusive dressing may increase systemic absorption and possibly toxicity
Kaposi’s sarcoma reported with prolonged corticosteroid therapy
Children may exhibit greater susceptibility to corticosteroid-induced HPA axis suppression and Cushing’s syndrome due to larger skin surface area to body weight ratio
Peripheral neuropathy may occur with prolonged use of high doses
Optic neuritis may occur with prolonged use of high doses; avoid long term therapy
Peripharal neuropathy may occur with prolonged use of high doses; avoid long term therapy
Use caution in patients with thyroid disease
Pregnancy and Lactation
Pregnancy Category: C
Lactation: not known whether either drug applied topically enters breast milk; use caution
Maximum Dosage
Maximum dosage information is not available.
Maximum dosage information is not available.
Maximum dosage information is not available.
12 years and older: Maximum dosage information is not available.
Less than 12 years: Safety and efficacy have not been established.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Hydrocortisone acetate/iodoquinol
Hydrocortisone/iodoquinol
cream
- 1%/1%
- 2%/1%